Blog - QualityStocks

MondayAug 10, 2026 10:50 am

QualityStocksNewsBreaks – AZIO AI Holdings, Inc. (NASDAQ: AZIO) Featured in AINewsWire Editorial on AI Power, Infrastructure Demand

AZIO AI Holdings (NASDAQ: AZIO) is featured in an AINewsWire editorial titled “As AI Races Ahead, the Real Battle Is Over Power and Infrastructure,” examining how accelerating artificial intelligence adoption is driving demand for the physical infrastructure required to support AI computing. The editorial highlights AZIO AI integrated infrastructure strategy, including its planned 500-megawatt Texas AI data-center campus, Master Services Agreement with AT&T for enterprise fiber connectivity and power purchase and AI infrastructure hosting agreement with Power Champion Investment Limited. The editorial also highlights AZIO AI recently announced letter of intent with Power Champion for the proposed acquisition of 128…

MondayAug 10, 2026 9:30 am

QualityStocksNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Secures $10 Million Strategic Private Placement With Eric Sprott

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) announced a strategic non-brokered private placement with Eric Sprott for gross proceeds of $10 million. The financing consists of 4 million units priced at $2.50 each, to be subscribed for by 2176423 Ontario Ltd., a corporation beneficially owned by Sprott. Each unit includes one common share and one warrant exercisable at $3.25 for 24 months. Closing is anticipated on or about Aug. 17, 2026, subject to customary conditions, including Canadian Securities Exchange approval. MAX Power…

MondayAug 10, 2026 9:10 am

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS into Phase 2

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) announced that the U.S. Food and Drug Administration has approved its Investigational New Drug (“IND”) application for Lucid-MS (Lucid-21-302), clearing the company to advance the patented, first-in-class multiple sclerosis candidate into Phase 2 clinical development. The planned randomized, double-blind, placebo-controlled study will evaluate efficacy, safety and tolerability in people with MS using clinical and radiological measures. Trial start-up activities, including site selection, are underway, with patient enrollment and drug administration expected to begin as quickly as possible. Lucid-MS…

FridayAug 07, 2026 2:55 pm

QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Closer to Regulatory and Commercial Milestones

Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel-based cartilage regeneration technology toward key clinical, regulatory and commercial milestones amid growing interest in regenerative orthopedic solutions. GelrinC is an off-the-shelf, cell-free implant designed for a streamlined, single-step procedure that supports cartilage regeneration without the cell harvesting and laboratory processing required by some alternative approaches. Regentis is continuing enrollment in its U.S. clinical study, preparing for a potential FDA Premarket Approval submission, expanding commercialization efforts in Europe following CE Mark approval, and optimizing manufacturing for scalability and consistency. To view the full article, visit https://ibn.fm/mVCsB About Regentis Biomaterials Ltd. Regentis Biomaterials is a…

FridayAug 07, 2026 2:12 pm

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Two-Pronged Approach to Neurological Health

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM), a biopharmaceutical company focused on advancing innovative therapies and technologies, is developing a two-pronged strategy addressing neurological health through its investigational multiple sclerosis therapy Lucid-MS and its proprietary dietary supplement unbuzzd. Lucid-MS is designed to target PAD2, an enzyme associated with myelin degradation, with the goal of protecting and potentially restoring the myelin sheath rather than primarily modulating the immune system. The company submitted an IND application to the FDA for a Phase 2 trial and is supporting development through an imaging collaboration…

FridayAug 07, 2026 1:04 pm

QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Builds Strategic Position in Antibody Therapeutics Market

VERAXA Biotech (NASDAQ: VRXA) is developing next-generation antibody therapeutics across antibody-drug conjugates (“ADCs”) and T-cell engagers (“TCEs”), two areas that continue to attract significant pharmaceutical investment. A recent article highlights major transactions to illustrate how differentiated antibody-engineering platforms can attract substantial financial commitments even before clinical development reaches advanced stages. VERAXA’s proprietary BiTAC platform supports a pipeline that includes bispecific ADCs, T-cell engagers and engineered antibody formats, potentially creating opportunities for future platform partnerships, licensing agreements or asset-level transactions. To view the full article, visit https://ibn.fm/sMjlp About VERAXA Biotech AG VERAXA is building a premier engine for the discovery and development of…

FridayAug 07, 2026 11:15 am

Wrap Technologies Inc. (NASDAQ: WRAP) Positions Non-Lethal Innovation at the Center of Public Safety Reform

WRAP offerings illustrate a broader industry trend toward building connected ecosystems rather than standalone products. High-profile use-of-force incidents have driven costly litigation and increased scrutiny on how officers are equipped and trained. The company’s Non-Lethal Response(TM) platform combines remote restraint, training and evidence management. Across the United States, a quiet but consequential shift is underway in how communities approach public safety. Rather than treating equipment, training and accountability as separate priorities, agencies are increasingly seeking integrated systems that connect the tools officers carry with the training that prepares them and the data that documents every encounter. This full-stack approach reflects…

FridayAug 07, 2026 10:37 am

QualityStocksNewsBreaks – AZIO AI Holdings, Inc. (NASDAQ: AZIO) Featured in AINewsWire Editorial on AI Compute Infrastructure

AZIO AI Holdings (NASDAQ: AZIO) announced its inclusion in an AINewsWire ("AINW") editorial examining the growing shortage of AI compute infrastructure and its implications for the next phase of artificial intelligence adoption. The editorial, titled "The Compute Shortage Threatening AI's Next Growth Phase," highlights industry forecasts calling for an estimated $6.7 trillion in AI-related data center investment by 2030 and discusses AZIO's strategy to address increasing demand for AI compute capacity. The editorial also spotlights AZIO's recently announced agreement with Power Champion Investment Limited for the purchase of up to 128 NVIDIA(TM) B300 GPU systems, positioning the company as an emerging provider of AI infrastructure. The editorial notes that the…

FridayAug 07, 2026 10:30 am

Brownfield Gold Projects Could Hold an Edge in Today’s Permitting Environment

Disseminated on behalf of  Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising. Santa Fe is a past-producing brownfield project targeting a 2027 restart, leveraging existing infrastructure to reduce capital requirements and execution risk Groundwater drilling did not intercept the water table beneath the proposed pits, a permitting advantage, while 40 years of undisturbed Corona-era waste rock shows no sign of acid drainage An updated Mineral Resource Estimate is expected and a revised PEA by the end of August, building on a 2025 study that outlined a $200 million after-tax NPV and a 34.2% IRR As permitting timelines…

FridayAug 07, 2026 9:45 am

Forward Industries Inc. (NASDAQ: FWDI) Slates Web Conference to Discuss Q3 Results, SOL Treasury Strategy

Texas-based Solana treasury company Forward Industries has announced a planned webcast leadership discussion of Q3 financial results and a follow-up Q&A on Aug. 12 Forward Industries is the world’s largest holder of the native Solana cryptocurrency SOL, managing more than 1% of the total supply The company aims to not only hold SOL but to achieve investment returns that beat market benchmarks, allowing Forward to generate cash flow through staking Solana is a public blockchain platform that uses smart contracts to support decentralized finance (“DeFi”) applications and SOL's market cap is the seventh largest crypto By far the world’s leading…

Site Search

Company Search